Matching slides 8,343
Current window 5,641-5,670
Pages 279
Rows per page 30
Tool: Chart Selection Guideclear collectionreset all

Tool

5,641-5,670 of 8,343

filter-aware
15
Includes footnotes explaining non-recurring items and reconciliation references.AgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations Beat · Financials1 hit
03
Uses a combination of pie charts for global stats and a process diagram for supply chain breakdown.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
27
The slide uses a three-column layout to present performance metrics across three distinct operational areas.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
14
The slide uses a combination of a line chart for TSR and a grouped bar chart for valuation multiples to demonstrate the market downturn.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · AgitateLoop · Cost Of Inaction1 hit
15
The slide uses two bar charts to illustrate the widening of high-yield spreads and the decline in transaction volume as evidence of a difficult financing environment.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart uses a stacked bar approach to show captured vs. estimated visits, with trend lines indicating growth rates.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
17
Includes Kaplan-Meier survival curve and comparative efficacy tables.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
19
Spider plot (swimmer plot variant) showing individual patient tumor response trajectories.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
23
Includes statistical significance markers (*, **, ***) and TGI (Tumor Growth Inhibition) percentages.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
07
Includes box plot showing 10th/90th percentiles and line chart showing concentration over 20 minutes.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
32
The chart uses a color shift to distinguish historical data from the forecast period.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
27
The slide uses a pathway diagram and a bar chart to demonstrate the mechanism of action of AXA1125 in a Primary Human Hepatocyte (PHH) Lipotoxicity Model.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
32
Includes a map-based visualization of regional prevalence and a grouped bar chart for age/sex demographics.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The chart tracks two distinct asset classes over an 11-year period, with a secondary metric (ITG) presented below the x-axis.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
19
The charts show dose-response curves where the proprietary antibodies (IM301, IM302) maintain high binding to CLDN6 while showing minimal off-target binding compared to the benchmark.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide compares the library against a benchmark (IMAB027) in terms of reactivity and cytotoxicity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · Key Takeaways1 hit
31
The chart illustrates a transition in export models starting in 2023, with IHS Export data ending in 2025.Evercore | Investment Banking Pitch Book | 56 slides · Evercore
Consulting deck Investment bank Beat · Evidence & ProofLoop · Zoom In1 hit
22
Includes historical data (2012A-2021A) and projections (2022E-2028E).Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
25
The slide uses a combination of bar charts for employee counts and cost per ton, and a line chart for the average fully-loaded cost per employee.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
36
The slide compares two financial scenarios across three key metrics over a 7-year period.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
40
The chart uses a floating bar (waterfall-style) representation to show valuation ranges. Proposed consideration is marked at $17.90.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
19
The slide uses a circular visualization for epigenetic clock/molecular health and three big numbers for survey results.Foxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · Satisfaction1 hit
65
The chart compares brands across different years (2019, 2021, 2022).Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
78
The chart shows a significant increase in efficacy between week 2 and week 8.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
102
The slide highlights financial performance consistency and upward revisions in guidance.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
106
The chart uses a grouped bar format to compare two metrics across four quarters, with a specific callout box for Q4.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a combination of a photo background with overlaid text and two line charts to illustrate the trend of decreasing CapEx and improving EBITDA across various farm locations.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
05
The slide uses two donut charts to visualize geographic and channel distribution, alongside icons for product and gender demographics.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
17
The chart highlights a projected revenue increase of $2-2.5B between 2022E and 2027E.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit